HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manja Lehmann Selected Research

Manja Lehmann Research Topics

Disease

13Alzheimer Disease (Alzheimer's Disease)
01/2018 - 01/2009
7Atrophy
01/2019 - 01/2009
2Cerebral Cortical Thinning
11/2016 - 01/2009
2Dementia (Dementias)
07/2015 - 07/2011
2Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
06/2013 - 03/2012
1Corticobasal Degeneration
08/2017
1Lewy Body Disease (Lewy Body Dementia)
08/2017
1Prion Diseases (Transmissible Spongiform Encephalopathies)
08/2017
1Amyloid Plaque
07/2015
1Pica (Geophagia)
01/2014
1Cognitive Dysfunction
01/2013
1Primary Progressive Nonfluent Aphasia (Progressive Nonfluent Aphasia)
07/2011
1Aphasia (Dysphasia)
07/2011

Drug/Important Bio-Agent (IBA)

6Amyloid (Amyloid Fibrils)IBA
12/2015 - 03/2013
4Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2013
3Pemetrexed (MTA)FDA Link
01/2013 - 12/2011
2Biological FactorsIBA
01/2019 - 04/2013
22- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
07/2015 - 03/2013
2ApolipoproteinsIBA
03/2014 - 01/2009
2Glucose (Dextrose)FDA LinkGeneric
01/2014 - 03/2013
2ProgranulinsIBA
06/2013 - 07/2011
1NeurograninIBA
01/2018
1PrionsIBA
08/2017
1Flavin-Adenine Dinucleotide (FAD)IBA
11/2016
1Apolipoprotein E4IBA
03/2014
1Apolipoproteins E (ApoE)IBA
01/2009

Therapy/Procedure

1Therapeutics
01/2014